Inventor · disambiguated record
Rhonan Ford
Also filed as: FORD RHONAN · FORD RHONAN LEE
8 granted patents·13 pending applications·19 citations·filing 2003–2018
80Inventor score
Top patents by PatentIndex Score
21 records- 0174US7227038B2Adamantane derivatives, processes for their preparation and pharmaceutical composition containing themASTRAZENECA AB·Filed 2004·Granted Jun 5, 2007·10 cites·16 claims
- 0268US10150723B2Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-oneNOVASSAY S A·Filed 2016·Granted Dec 11, 2018·1 cites·23 claims
- 0368US8193239B2Substituted 1-cyanoethylheterocyclylcarboxamide compoundsFORD RHONAN·Filed 2010·Granted Jun 5, 2012·3 cites·9 claims
- 0465US7408065B2P2X7 receptor antagonists and their useASTRAZENECA AB·Filed 2004·Granted Aug 5, 2008·4 cites·8 claims
- 0562US8329729B2Quinuclidine derivatives as muscarinic M3 receptor antagonistsBULL RICHARD JAMES·Filed 2008·Granted Dec 11, 2012·1 cites·7 claims
- 0652US9382295B2Cyclic depsipeptide compounds and their usesCYPRALIS LTD·Filed 2013·Granted Jul 5, 2016·0 cites·20 claims
- 0750US2009018133A1Novel Adamantane DerivativesFORD RHONAN·Filed 2008·Application pending·0 cites
- 0850US2009143354A1P2X7 Receptor Antagonists and Their UseEVANS RICHARD·Filed 2008·Application pending·0 cites
- 0950US2018153958A1Cyclic depsipeptide compounds and their usesCYPRALIS LTD·Filed 2018·Application pending·0 cites
- 1048US8207193B2Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonistsFORD RHONAN·Filed 2007·Granted Jun 26, 2012·0 cites·15 claims
- 1147US9895412B2Cyclic depsipeptide compounds and their usesCYPRALIS LTD·Filed 2016·Granted Feb 20, 2018·0 cites·18 claims
- 1246US2005090524A1Novel adamantane derivativesFiled 2003·Application pending·0 cites
- 1346US2007037830A12-Adamantyl derivatives as p2X7 receptor antagonists.ASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1443US2013005695A1Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonistsASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 1542US2011190309A1PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONISTFORD RHONAN·Filed 2009·Application pending·0 cites
- 1642US2010113510A1Quinuclidinol derivatives as muscarinic receptor antagonistsFORD RHONAN·Filed 2007·Application pending·0 cites
- 1739US2012329775A1Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750FORD RHONAN·Filed 2012·Application pending·0 cites
- 1839US2008182874A1Novel CompoundsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1938US2008058293A1Quinoline Derivates and Their Use in TherapyFORD RHONAN·Filed 2004·Application pending·0 cites
- 2038US2008153850A1Adamantyl Derivates as P2x7 Receptor AntagonistsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2133US2013030001A1Quinuclidine derivatives as muscarinic m3 receptor antagonistsPULMAGEN THERAPEUTICS SYNERGY·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →